Five women were studied under single-blind conditions in a private clinical setting ( 2 of them were referred specifically for treatment-resistant menstrual-related symptoms ) ; 6 women completed a double-blind crossover study of chromium plus placebo versus chromium plus sertraline in a university clinical research setting .